Dr. Angelos M. Stergiou, MD, ScD h.c. is CEO and Vice Chairman of the company behind the WT1 cancer vaccine, SELLAS Life Sciences Group. Prior to founding the company, Dr. Stergiou had worked in a number of positions in biotechnology and pharmaceutical companies in Europe and the United States. Today, he is enjoying his work in the biotechnology sector, a passion of his. In reference to founding SELLAS Life Sciences, he said:
“It combines medicine, research and business, and I truly love doing this every day.” He went on to state: “The thirst to get to the finish line and get [the WT1 cancer vaccine] approved, so we can potentially save lives, is breathtaking.”
Visit https://angelosstergiou.wordpress.com/about-angelos-stergiou to know more bout him.